Completed OBSERVATIONAL NCT04543175

Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.

Taste Disorders and Their Relation to Body Mass Index, Food Frequency Questionnaire and Quality of Life in Breast Cancer Patients During Chemotherapy.

Sponsor: Hospital General de Mexico

Conditions Ageusia Breast Cancer Dysgeusia Quality of Life Taste Disorders

Interventions Taste disorder´s test

Updated 4 times since 2020 Last updated: Sep 2, 2020 Started: Jan 1, 2017 Primary completion: Jan 1, 2018 Completion: Jan 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04543175, this observational or N/A phase trial focuses on Ageusia and Breast Cancer and remains completed. Sponsored by Hospital General de Mexico, it has been updated 4 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Oct 2020 — Jan 2021 [monthly]

Completed

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital General de Mexico

Data source: Hospital General de Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico